Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- PMID: 33583576
- PMCID: PMC7833665
- DOI: 10.1016/j.clinthera.2021.01.015
Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
Abstract
This review describes the sex and gender differences in COVID-19 presentation, treatment, and outcomes. We discuss the differences between the sexes in susceptibility to infection, the role of sex chromosomes on the body's immunologic response and the influence of hormones on the body's response to the virus. Additionally, the sex differences in clinical and laboratory presentation, complications of infection and outcomes, as well as differences in response to treatment and prevention are reviewed.
Keywords: Immunology; Sars Cov2; long haulers; sex and gender based medicine; sex-disaggregated analysis.
Copyright © 2021 Elsevier Inc. All rights reserved.
References
-
- World Health Organization (WHO) 2020. WHO Interactive Timeline.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interact... [WHO website] Available from:
-
- World Health Organization (WHO) 2020. Timeline of WHO’s Response to COVID-19.https://www.who.int/news-room/detail/29-06-2020-covidtimeline [WHO website] Available from:
-
- Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151. https://pubmed.ncbi.nlm.nih.gov/32064853/ [in Chinese] - PubMed
-
- The COVID-19 Sex-Disaggregated Data Tracker. 2020. https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker [Global Health 50/50 website] Available from:
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
